By engaging Baker IDI in the development of health related publications, our partners and audiences of these publications, can be assured that they will contain up to date, relevant and accurate information and backing from a highly reputable scientific organisation.
Name of partner: Penguin Books
‘Diabetes Diet and Lifestyle Plan book'- The production of a book by experts in the field that provides tips, strategies and recipes for people with diabetes
Penguin Group has had a presence in the publishing space since 1935, and has grown to become a multinational force in publishing and home to some of Australia's bestselling and award-winning writers and illustrators.
The Diabetes Diet and Lifestyle Plan book was a first time collaboration of Penguin, CSIRO, and Baker IDI which produced a comprehensive resource to support a healthy lifestyle, covering every aspect of diabetes prevention and control. It has allowed internationally-renowned Australian researchers and clinicians to communicate effective strategies and tools for preventing and controlling diabetes to people at risk of developing diabetes and those living with diabetes.
This very popular book provides practical diets and recipes, exercise programs and checklists for diabetes control and has so far sold well in excess of 20,000 copies and made the best sellers list. This collaboration is an example of how the translation of scientific information can have a wide reaching impact within the community.
Name of partner: Boehringer Ingelheim
Deloitte Access Economics - Expert content revision and media support for a report on the economic burden of Atrial Fibrillation in Australia
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies, and has a focus on researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
Baker IDI partnered with Boehringer Ingelheim to produce an Access Economics report on Atrial Fibrillation. The quantification of the economic burden of a disease in these reports are an important and a necessary step in understanding the effect a disease is having on a society at large. These economic metrics help identify efficient methods of addressing the disease burden.
Baker IDI provided access to our cardiovascular expertise to review the content of the report and provide media support for the public launch of the report. The Access Economics report estimated the potential health benefits and opportunity costs associated with the detection and best practice management of Atrial Fibrillation in Australia.